This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: The Innovative Mind of Ho-Yin Lo: A Contributor to Pharmaceutical Advancements
Introduction
Ho-Yin Lo is a prominent inventor based in Bethel, CT, known for his significant contributions to the field of pharmaceuticals. With one patent to his name, he stands out as an innovator dedicated to improving medical treatments and healthcare solutions.
Latest Patents
Ho-Yin Lo's notable patent focuses on "Benzimidazole inhibitors of leukotriene production." This invention pertains to compounds that inhibit the production of leukotrienes, which play a role in various diseases and disorders. The patent details these compounds' formula and their pharmaceutically acceptable salts, offering insights into pharmaceutical compositions that include these compounds. Furthermore, it outlines methods for utilizing these compounds to treat various health conditions and describes processes for their preparation, along with intermediates useful in these methodologies.
Career Highlights
Throughout his career, Ho-Yin Lo has associated himself with Boehringer Ingelheim International GmbH, a leading company in the pharmaceutical industry. His work involves, not only the advancement of innovative treatments but also the collaboration with an elite team of researchers and professionals in the field. His passion and commitment to his work are evident in the impact of his inventions.
Collaborations
Ho-Yin Lo has collaborated with esteemed coworkers, including Zhidong Chen and Ming-Hong Hao. Their collective efforts and expertise have contributed to the success of various research projects, enhancing the potential for breakthroughs in pharmaceutical treatments.
Conclusion
In conclusion, Ho-Yin Lo exemplifies the innovative spirit of today’s inventors in the pharmaceutical profession. His contributions, especially in the form of his patent for benzimidazole inhibitors, reflect a dedication to advancing healthcare solutions. As he continues to work with Boehringer Ingelheim International GmbH and collaborate with talented individuals in his field, he remains a key player in the journey towards effective treatments for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile